Dna X (SONM) Free Cash Flow (2018 - 2026)

Dna X has reported Free Cash Flow for 9 years, with the latest figure at -$3.5 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 63.92% year-over-year to -$3.5 million; the trailing twelve-month figure through Mar 2026 stood at -$17.4 million (up 3.99% YoY), and the FY2025 full-year result was -$23.5 million, down 170.41% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$3.5 million, down from -$2.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $820000.0 in Q2 2023, with the low at -$10.3 million in Q3 2022.
• Historically, Free Cash Flow has averaged -$3.1 million across 5 years, with a median of -$2.2 million in 2022.
• Annual changes were most pronounced in 2022 — Free Cash Flow soared 110.86% — and 2025, when it tumbled 4751.52%.
• Dna X's Free Cash Flow stood at -$2.2 million in 2022, then soared by 83.69% to -$363000.0 in 2023, then plunged by 1144.35% to -$4.5 million in 2024, then soared by 55.63% to -$2.0 million in 2025, then plunged by 72.95% to -$3.5 million in 2026.
• The last three Free Cash Flow figures came in at -$3.5 million (Q1 2026), -$2.0 million (Q4 2025), and -$7.0 million (Q3 2025), per Business Quant data.